Elliott Winton

Contact Information:

Phone: 404-778-1900

Email: ewinton@emory.edu

View Emory directory entry

School/Division:

Professor

SOM: HMO: Hematology

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 11

  1. 1
  2. 2

Article

Long-term Treatment With Rituximab of Autoimmune Autonomic Ganglionopathy in a Patient With Lymphoma

by Ryan Hollenbeck; Bonnie K. Black; Amanda C. Peltier; Italo Biaggioni; David Robertson; Elliott Winton; Satish R. Raj

2011

Article

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.

by John O. Mascarenhas; Moshe Talpaz; Vikas Gupta; Lynda M. Foltz; Michael R. Savona; Ronald Paquette; A. Robert Turner; Paul Coughlin; Elliott Winton; Timothy C. Burn; Peter O'Neill; Jason Clark; Deborah Hunter; Albert Assad; Ronald Hoffman; Srdan Verstovsek

2017

Article

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

by Ruben A. Mesa; Jason Gotlib; Vikas Gupta; John V. Catalano; Michael W. Deininger; Alan L. Shields; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Thomas Hare; Susan Erickson-Viitanen; William Sun; Victor Sandor; Richard S. Levy; Hagop M. Kantarjian; Srdan Verstovsek

2013

Article

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis

by Ruben A. Mesa; Jean-Jacques Kiladjian; John V. Catalano; Timothy Devos; Miklos Egyed; Andrzei Hellmann; Donal McLornan; Kazuya Shimoda; Elliott Winton; Wei Deng; Ronald L. Dubowy; Julia D. Maltzman; Francisco Cervantes; Jason Gotlib

2017

Article

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael Deininger; Carole Miller; Richard T. Silver; Moshe Talpaz; Elliott F Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

Ruxolitinib for the treatment of patients with polycythemia vera

by Jean-Jacques Kiladjian; Elliott Winton; Moshe Talpaz; Srdan Verstovsek

2015

Article

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

by Moshe Talpaz; Ronald Paquette; Lawrence Afrin; Solomon I Hamburg; Josef T Prchal; Katarzyna Jamieson; Howard R Terebelo; Gregory L Ortega; Roger M Lyons; Ramon V Tiu; Elliott Winton; Kavita Natrajan; Olatoyosi Odenike; David Claxton; Wei Peng; Peter O’Neill; Susan Erickson-Viitanen; Lance Leopold; Victor Sandor; Richard S Levy; Hagop M Kantarjian; Srdan Verstovsek

2013

Article

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael W. N. Deininger; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth O. Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

by Ruben A. Mesa; Jean-Jacques Kiladjian; Srdan Verstovsek; Haifa Kathrin Al-Ali; Jason Gotlib; Heinz Gisslinger; Richard Levy; Andres Siulnik; Vikas Gupta; Mahmudul Khan; John F. DiPersio; Mari McQuitty; John V. Catalano; Deborah S. Hunter; Laurent Knoops; Michael Deininger; Francisco Cervantes; Carole Miller; Alessandro M. Vannucchi; Richard T. Silver; Tiziano Barbui; Moshe Talpaz; Giovanni Barosi; Elliot F. Mendeson; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; ROnald Paquette; Azra Raza; William Sun; Victor Sandor; Hagop M. Kantarjian; Claire Harrison

2014

Article

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia

by Kim-Hien T. Dao; Magdolna B. Solti; Julia E. Maxson; Elliott Winton; Richard D. Press; Brian J. Druker; Jeffrey W. Tyner

2014